This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
We’re just over a month away from the first Cancer Research Institute Immunotherapy Patient Summit and we’ve been blown away by the response to the event. The response has been so positive, we’ve had to increase capacity – twice! As excitement builds, we wanted to share a sneak peek of the programming we’re planning for the Summit. Here’s what to expect:
As you can see, we’re bringing attendees experts in a wide range of topics – from oncologists, to advocates, to patients who’ve experienced immunotherapy firsthand. We know this will be a valuable day to all to attend, and we’re proud to offer two ways to join in: either in person in New York City, or remotely, via our livestream. Either way, registration is free. Click here to register to join us on the 24th, either in NYC or remotely. The Cancer Research Institute Immunotherapy Patient Summit is made possible by generous support from Bristol-Myers Squibb, Merck, Genentech, and Regeneron. - See more at: http://www.cancerresearch.org/news-publications/our-blog/august-2016/immunotherapy-patient-summit-agenda-announced#sthash.GsCyDCrl.dpuf
Cancer Research Institute Featured in New York Times Cover Story on Cancer Immunotherapy
Read Previous Article
Immunotherapy Patient Summit Agenda – Announced!
Read Next Article
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).